Works perfectly
GLP-1 receptor agonists are medications that activate the GLP-1 receptor, resulting in several beneficial effects, including enhancing insulin secretion from pancreatic beta cells in response to elevated glucose, reducing glucagon secretion, slowing gastric emptying, and improving glucose disposal in peripheral tissues
That asymmetry has made BPC-157 unusual in the peptide landscape: widely used, extensively studied preclinically, yet almost entirely untested under controlled human conditions
That's why our protocol includes motility restoration, addressing underlying conditions like thyroid dysfunction or low stomach acid, and rebuilding the microbiome
Community reports describe not dramatic hypertrophy (ipamorelin is not anabolic steroids), but improved muscle quality better pumps during training, slightly fuller appearance, and improved nitrogen retention